Ranger Investment Management L.P. Takes $7.26 Million Position in Guardian Pharmacy Services, Inc. $GRDN

Ranger Investment Management L.P. purchased a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 173,458 shares of the company’s stock, valued at approximately $7,263,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Ameritas Investment Partners Inc. lifted its position in shares of Guardian Pharmacy Services by 26.5% during the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after buying an additional 345 shares during the last quarter. Raymond James Financial Inc. bought a new position in Guardian Pharmacy Services in the second quarter valued at about $43,000. State of Wyoming bought a new position in Guardian Pharmacy Services in the second quarter valued at about $58,000. Strs Ohio acquired a new position in Guardian Pharmacy Services during the fourth quarter worth about $75,000. Finally, Clearstead Advisors LLC raised its stake in Guardian Pharmacy Services by 196.3% during the fourth quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock worth $79,000 after acquiring an additional 1,741 shares in the last quarter.

Analysts Set New Price Targets

GRDN has been the subject of a number of research reports. Oppenheimer increased their target price on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a report on Friday, August 7th. Zacks Research lowered shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Truist Financial upped their price objective on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Wall Street Zen raised shares of Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Finally, Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday. Eight equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $43.83.

Guardian Pharmacy Services Stock Down 0.1%

Shares of GRDN stock opened at $37.90 on Monday. Guardian Pharmacy Services, Inc. has a twelve month low of $23.14 and a twelve month high of $47.02. The stock’s fifty day simple moving average is $40.44 and its 200 day simple moving average is $37.75. The firm has a market capitalization of $1.89 billion, a P/E ratio of 36.80, a P/E/G ratio of 1.96 and a beta of 0.11.

Guardian Pharmacy Services (NYSE:GRDN) last posted its earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%.The firm had revenue of $351.77 million during the quarter, compared to the consensus estimate of $340.45 million. As a group, equities research analysts expect that Guardian Pharmacy Services, Inc. will post 1.19 EPS for the current fiscal year.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.